Corona Virus Disease 2019 (COVID 2019), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a dreadful infectious disease which has emerged as one of the most significant medical emergency affecting everyone directly or indirectly. COVID 2019 is a multisystem disease and causes severe immunosuppression. Initially thought to affect mainly the respiratory system, it strikes all vital organ systems and cause defects in cardio-circulatory, respiratory system and gastrointestinal systems to name a few leading to copious biochemical alterations. Reports show there is thromoembolism, raised ferritin levels, lymphocytopenia, thrombocytopenia, lactic acidosis, acute diabetes like state and cytokine storm. Data regarding levels of neutrophils is equivocal. Further there is increased incidence regarding high incidents of mucormycosis in COVID 2019 positive subjects. In the present paper, we identified and correlated the virus mediated biochemical alterations as the potential ideal environment for propagation of mucorales; and thus concentrate on early diagnosis and treatment of mucormycosis in COVID 2019 cases.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8152198 | PMC |
| http://dx.doi.org/10.1016/j.mehy.2021.110613 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Longitudinal Follow-Up of the Specific Antibody Response to SARS-CoV-2 Vaccination in Colombia.
J Med Virol
January 2025
Centro Internacional de Vacunas, Cali, Colombia.
A total of 5011 adult volunteers attending vaccination centers in different regions of Colombia were enrolled in a 1-year prospective observational cohort study to evaluate the immunogenicity and effectiveness of SARS-CoV-2-based vaccines as part of a National Vaccine Program established to contain the COVID-19 pandemic. Following informed consent, 5,011 participants underwent a sociodemographic survey and PCR testing to assess SARS-CoV-2 infection. Blood samples were collected, and serum fractions were obtained from a participant subsample (n = 3441) at six-time points to assess virus-specific IgG responses to the Spike protein, its Receptor Binding Domain, and the Nucleoprotein by ELISA.
View Article and Find Full Text PDFArticles' retraction during the pandemic: COVID-19 is not the pacemaker.
Ann Transl Med
December 2024
Medical Direction, Rovereto Hospital, Provincial Agency for Social and Sanitary Services (APSS), Trento, Italy.
Insights from immunomics and metabolomics on the associations between prostatic diseases and coronavirus disease 2019.
Prostate Int
September 2024
Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei 230032, China.
Background: The causal associations and potential mechanisms between prostatic diseases, the predominant male urological disorders, and the course of COVID-19 remain unclear.
Methods: A two-sample Mendelian randomization (MR) analysis was performed to evaluate causal associations between prostate cancer, benign prostatic hyperplasia, and prostatitis and different COVID-19 outcomes (SARS-CoV-2 infection, hospitalized COVID-19, and severe COVID-19). Reverse MR, linkage disequilibrium score regression, and Bayesian colocalization analyses were subsequently performed to strengthen the identified causal relationships.
Estimating cumulative infection rate of COVID-19 after adjusting the dynamic zero-COVID policy in China.
Infect Dis Model
June 2025
School of Public Health, Nanjing Medical University, Nanjing, 211166, China.
Background: At the end of 2022, China adjusted its coronavirus disease 2019 (COVID-19) prevention and control strategy. How this adjustment affected the cumulative infection rate is debated, and how second booster dose vaccination affected the pandemic remains unclear.
Methods: We collected COVID-19 case data for China's mainland from December 7, 2022, to January 7, 2023, reported by the World Health Organization.
Classification of Severity of Lung Parenchyma Using Saliency and Discrete Cosine Transform Energy in Computed Tomography of Patients With COVID-19.
Int J Telemed Appl
January 2025
Medical Familiar Unit, Instituto de Seguridad y Servicios Sociales de Los Trabajadores del Estado, Torreón, Coahuila, Mexico.
This study proposes an automated system for assessing lung damage severity in coronavirus disease 2019 (COVID-19) patients using computed tomography (CT) images. These preprocessed CT images identify the extent of pulmonary parenchyma (PP) and ground-glass opacity and pulmonary infiltrates (GGO-PIs). Two types of images-saliency () image and discrete cosine transform (DCT) energy image-were generated from these images.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!